BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine

  June 23, 2025

   · 

  8 min read
• Press Releases

  Lilly’s once-weekly insulin efsitora alfa demonstrated A1C reduction and a safety profile consistent with daily insulin in multiple Phase 3 trials

  June 23, 2025

   · 

  11 min read
• Press Releases

  Once-Weekly Insulin Efsitora Achieves Comparable A1C Reduction to Daily Insulin Therapy

  June 23, 2025

   · 

  4 min read
• Press Releases

  Press Release: Sarclisa recommended for EU approval by the CHMP to treat transplant-eligible newly diagnosed multiple myeloma

  June 23, 2025

   · 

  9 min read
• Press Releases

  Final Data from Teva’s PEARL Real-World Study Reinforce the Long-term Effectiveness of AJOVY® (fremanezumab) for the Prevention of Chronic and Episodic Migraine

  June 23, 2025

   · 

  7 min read
• Press Releases

  Vertex and Ono Pharmaceutical Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea

  June 23, 2025

   · 

  10 min read
• Press Releases

  ITM and Debiopharm Announce First Patient Imaged in New Study Arm of Phase 1/2 Trial Evaluating ITM-94 as Diagnostic Agent for Clear Cell Renal Cell Carcinoma (ccRCC)

  June 23, 2025

   · 

  6 min read
• Press Releases

  Illuccix Approved in U.S. for Patient Selection for Pre-Taxane RLT

  June 23, 2025

   · 

  9 min read
• Press Releases

  AltruBio Presents New Preclinical Data at FOCIS 2025 Demonstrating ALTB-268’s Efficacy in T Cell-Mediated Inflammatory Models

  June 23, 2025

   · 

  4 min read
• Press Releases

  DARZALEX® (daratumumab) receives the first positive CHMP opinion for patients with high-risk smouldering multiple myeloma

  June 23, 2025

   · 

  13 min read